Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Avantogen Oncology Inc

+ Add to Watchlist


Company Profile for Avantogen Oncology Inc (AVTO)

Avantogen Oncology, Inc. acquires and develops pharmaceutical compounds focused on the treatment of cancer. The Company has a portfolio of several compounds targeted against various cancers and cancer related diseases. Avantogen seeks to license the compounds at an early stage of development, and then develop and commercialize them by partnering with pharmaceutical companies.

Contact Information

Avantogen Oncology Inc

530 South Lake Avenue
Pasadena, CA 91101
United States
Phone: 1-917-969-4681

Key Executives for Avantogen Oncology Inc (AVTO)

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil